Sagespring Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Buy
47,666
+2,444
+5% +$569K 0.21% 63
2025
Q4
$9.36M Buy
45,222
+2,660
+6% +$526K 0.17% 71
2025
Q3
$7.89M Buy
42,562
+7,036
+20% +$1.21M 0.15% 76
2025
Q2
$5.43M Buy
35,526
+3,367
+10% +$518K 0.12% 95
2025
Q1
$5.33M Buy
32,159
+5,539
+21% +$867K 0.13% 82
2024
Q4
$3.85M Buy
+26,620
New +$4.13M 0.1% 97

Other funds holding JNJ

Sagespring Wealth Partners's JNJ Position: Q1 2026 in Review

Sagespring Wealth Partners increased its Johnson & Johnson (JNJ) stake by 5.4% in Q1 2026, buying an estimated $569K and bringing the position to 47,666 shares worth $11.7M. The position accounts for 0.21% of the portfolio, ranked #63.

Sagespring Wealth Partners first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sagespring Wealth Partners held 47,666 shares of Johnson & Johnson worth $11.7M as of Q1 2026.
  • Sagespring Wealth Partners bought 2,444 Johnson & Johnson shares in Q1 2026, an estimated $569K.
  • Johnson & Johnson made up 0.21% of Sagespring Wealth Partners's portfolio in Q1 2026, its #63 holding.
  • Sagespring Wealth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.